JP2024517931A5 - - Google Patents

Info

Publication number
JP2024517931A5
JP2024517931A5 JP2023569823A JP2023569823A JP2024517931A5 JP 2024517931 A5 JP2024517931 A5 JP 2024517931A5 JP 2023569823 A JP2023569823 A JP 2023569823A JP 2023569823 A JP2023569823 A JP 2023569823A JP 2024517931 A5 JP2024517931 A5 JP 2024517931A5
Authority
JP
Japan
Prior art keywords
tmprss6
sequence
seq
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023569823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517931A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/028595 external-priority patent/WO2022240877A1/en
Publication of JP2024517931A publication Critical patent/JP2024517931A/ja
Publication of JP2024517931A5 publication Critical patent/JP2024517931A5/ja
Pending legal-status Critical Current

Links

JP2023569823A 2021-05-11 2022-05-10 抗tmprss6抗体及びその使用 Pending JP2024517931A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163187150P 2021-05-11 2021-05-11
US63/187,150 2021-05-11
PCT/US2022/028595 WO2022240877A1 (en) 2021-05-11 2022-05-10 Anti-tmprss6 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2024517931A JP2024517931A (ja) 2024-04-23
JP2024517931A5 true JP2024517931A5 (enExample) 2025-05-19

Family

ID=81927373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023569823A Pending JP2024517931A (ja) 2021-05-11 2022-05-10 抗tmprss6抗体及びその使用

Country Status (14)

Country Link
US (2) US12448435B2 (enExample)
EP (1) EP4337695A1 (enExample)
JP (1) JP2024517931A (enExample)
KR (1) KR20240005894A (enExample)
CN (1) CN117730099A (enExample)
AU (1) AU2022274888A1 (enExample)
BR (1) BR112023023558A2 (enExample)
CA (1) CA3218455A1 (enExample)
CL (1) CL2023003331A1 (enExample)
CO (1) CO2023016777A2 (enExample)
IL (1) IL308375A (enExample)
MA (1) MA63064B1 (enExample)
MX (1) MX2023013248A (enExample)
WO (1) WO2022240877A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022240877A1 (en) 2021-05-11 2022-11-17 Regeneron Pharmaceuticals, Inc. Anti-tmprss6 antibodies and uses thereof
WO2024211404A2 (en) * 2023-04-04 2024-10-10 Disc Medicine, Inc. Anti-tmprss6 antibodies and uses thereof
WO2025245434A1 (en) * 2024-05-24 2025-11-27 Disc Medicine, Inc. Compositions and methods for treating myelodysplastic syndromes (mds)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20040101920A1 (en) 2002-11-01 2004-05-27 Czeslaw Radziejewski Modification assisted profiling (MAP) methodology
US7850962B2 (en) 2004-04-20 2010-12-14 Genmab A/S Human monoclonal antibodies against CD20
US8257740B1 (en) 2011-08-15 2012-09-04 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8246995B2 (en) 2005-05-10 2012-08-21 The Board Of Trustees Of The Leland Stanford Junior University Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
JP5307708B2 (ja) 2006-06-02 2013-10-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトil−6受容体に対する高親和性抗体
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
TWI635098B (zh) 2013-02-01 2018-09-11 再生元醫藥公司 含嵌合恆定區之抗體
CA2991637C (en) 2015-07-31 2022-07-05 Medimmune Limited Methods for treating hepcidin-mediated disorders
KR20220107252A (ko) * 2019-11-29 2022-08-02 키맵 리미티드 생리학적 철분 과다에 대한 치료
CN115243762A (zh) * 2020-04-07 2022-10-25 迈威(美国)生物治疗有限公司 抗tmprss6抗体及其用途
WO2022240877A1 (en) 2021-05-11 2022-11-17 Regeneron Pharmaceuticals, Inc. Anti-tmprss6 antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2024517931A5 (enExample)
JP2009518005A5 (enExample)
JP2020537520A5 (enExample)
JP2020124199A5 (enExample)
RU2014152006A (ru) Молекулы, связывающие il-6
JP2015518857A5 (enExample)
RU2012107286A (ru) Высокоаффинные человеческие антитела к человеческому ангиопоэтину-2
JP2017505125A5 (enExample)
JP2023519100A5 (enExample)
JP2015535828A5 (enExample)
JP2012525829A5 (enExample)
JP2013056885A5 (enExample)
AR069062A1 (es) Anticuerpo anti-hepcidina
RU2009105401A (ru) Антагонисты активируемого протеазой рецептора-1(раr1)
JP2012532851A5 (enExample)
AU2012311443B2 (en) Prolonged inhibition of interleukin-6 mediated signaling
CN112334488B (zh) 靶向免疫检查点的双特异性抗体
RU2012103212A (ru) Tlr3 связывающие агенты
JP2010501164A5 (enExample)
JP2020515277A5 (enExample)
CN104507964A (zh) P2x7受体拮抗剂和激动剂
IL323510A (en) Antibodies directed against 1PDL and methods of use thereof
WO2012021475A2 (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
JP2024109911A5 (enExample)
US20260098084A1 (en) Anti-tmprss6 antibodies and uses thereof